{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:31:44Z","timestamp":1770996704751,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the TianYuan funds for Mathematics of the National Science Foundation of China","award":["12326604"],"award-info":[{"award-number":["12326604"]}]},{"name":"Supported by Natural Science Foundation of Henan","award":["222300420538"],"award-info":[{"award-number":["222300420538"]}]},{"name":"Key Scientific Research Project of Henan Province Colleges and Universities","award":["22A416002"],"award-info":[{"award-number":["22A416002"]}]},{"name":"Macau Science and Technology Development fund","award":["FDCT (0012\/2021\/AMJ, 003\/2022\/ALC, 0092\/2022\/A2,0144\/2022\/A3)"],"award-info":[{"award-number":["FDCT (0012\/2021\/AMJ, 003\/2022\/ALC, 0092\/2022\/A2,0144\/2022\/A3)"]}]},{"name":"Shenzhen-Hong Kong-Macao Science and Technology Fund","award":["SGDX20220530111203020"],"award-info":[{"award-number":["SGDX20220530111203020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"DOI":"10.1186\/s13321-025-01085-2","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T09:44:20Z","timestamp":1760435060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["SMPR: a structure-enhanced multimodal drug\u2012disease prediction model for drug repositioning and cold start"],"prefix":"10.1186","volume":"17","author":[{"given":"Xin","family":"Dong","sequence":"first","affiliation":[]},{"given":"Rui","family":"Miao","sequence":"additional","affiliation":[]},{"given":"Suyan","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Shuaibing","family":"Jia","sequence":"additional","affiliation":[]},{"given":"Leifeng","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Yong","family":"Liang","sequence":"additional","affiliation":[]},{"given":"Jianhua","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Yi Zhun","family":"Zhu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"1085_CR1","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.2147\/DDDT.S327193","volume":"15","author":"R Abdelmonem","year":"2021","unstructured":"Abdelmonem R, Abdellatif MM, Al-Samadi IEI, El-Nabarawi MA (2021) Formulation and evaluation of Baclofen-Meloxicam orally disintegrating tablets (ODTs) using co-processed excipients and improvement of ODTs performance using Six Sigma method. Drug Des Devel Ther 15:4383\u20134402. https:\/\/doi.org\/10.2147\/DDDT.S327193","journal-title":"Drug Des Devel Ther"},{"key":"1085_CR2","doi-asserted-by":"crossref","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, Ronneberger O, Willmore L, Ballard AJ, Bambrick J (2024) Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 1\u20133.","DOI":"10.1038\/s41586-024-08416-7"},{"key":"1085_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.semcancer.2020.01.010","volume":"68","author":"MF Adasme","year":"2021","unstructured":"Adasme MF, Parisi D, Sveshnikova A, Schroeder M (2021) Structure-based drug repositioning: potential and limits. Semin Cancer Biol 68:192\u2013198. https:\/\/doi.org\/10.1016\/j.semcancer.2020.01.010","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"1085_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.seizure.2009.02.002","volume":"18","author":"Y Akgun","year":"2009","unstructured":"Akgun Y, Soysal A, Atakli D, Yuksel B, Dayan C, Arpaci B (2009) Cortical excitability in juvenile myoclonic epileptic patients and their asymptomatic siblings: a transcranial magnetic stimulation study. Seizure 18(6):387\u2013391","journal-title":"Seizure"},{"issue":"3","key":"1085_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/mds.28355","volume":"36","author":"DD Bushart","year":"2021","unstructured":"Bushart DD, Huang H, Man LJ, Morrison LM, Shakkottai VG (2021) A chlorzoxazone-baclofen combination improves cerebellar impairment in spinocerebellar ataxia type 1. Mov Disord 36(3):622\u2013631. https:\/\/doi.org\/10.1002\/mds.28355","journal-title":"Mov Disord"},{"issue":"6","key":"1085_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab319","volume":"22","author":"L Cai","year":"2021","unstructured":"Cai L, Lu C, Xu J, Meng Y, Wang P, Fu X, Zeng X, Su Y (2021) Drug repositioning based on the heterogeneous information fusion graph convolutional network. Brief Bioinform 22(6):bbab319","journal-title":"Brief Bioinform"},{"issue":"3","key":"1085_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1200\/JCO.1998.16.3.907","volume":"16","author":"R Consolini","year":"1998","unstructured":"Consolini R, Pui CH, Behm FG, Raimondi SC, Campana D (1998) In vitro cytotoxicity of docetaxel in childhood acute leukemias. J Clin Oncol 16(3):907\u2013913. https:\/\/doi.org\/10.1200\/JCO.1998.16.3.907","journal-title":"J Clin Oncol"},{"issue":"15","key":"1085_CR8","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.1021\/jm300576q","volume":"55","author":"S Dakshanamurthy","year":"2012","unstructured":"Dakshanamurthy S, Issa NT, Assefnia S, Seshasayee A, Peters OJ, Madhavan S, Uren A, Brown ML, Byers SW (2012) Predicting new indications for approved drugs using a proteochemometric method. J Med Chem 55(15):6832\u20136848. https:\/\/doi.org\/10.1021\/jm300576q","journal-title":"J Med Chem"},{"issue":"D1","key":"1085_CR9","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","volume":"49","author":"AP Davis","year":"2021","unstructured":"Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC, Mattingly CJ (2021) Comparative toxicogenomics database (CTD): update 2021. Nucleic Acids Res 49(D1):D1138\u2013D1143. https:\/\/doi.org\/10.1093\/nar\/gkaa891","journal-title":"Nucleic Acids Res"},{"key":"1085_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106639","volume":"188","author":"M Di Francesco","year":"2023","unstructured":"Di Francesco M, Pastorino F, Ferreira M, Fragassi A, Di Francesco V, Palange AL, Celia C, Di Marzio L, Cilli M, Bensa V, Ponzoni M, Decuzzi P (2023) Augmented efficacy of nano-formulated docetaxel plus curcumin in orthotopic models of neuroblastoma. Pharmacol Res 188:106639. https:\/\/doi.org\/10.1016\/j.phrs.2022.106639","journal-title":"Pharmacol Res"},{"key":"1085_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","volume":"47","author":"JA DiMasi","year":"2016","unstructured":"DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: new estimates of R&d costs. J Health Econ 47:20\u201333. https:\/\/doi.org\/10.1016\/j.jhealeco.2016.01.012","journal-title":"J Health Econ"},{"key":"1085_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/msb.2011.26","volume":"7","author":"A Gottlieb","year":"2011","unstructured":"Gottlieb A, Stein GY, Ruppin E, Sharan R (2011) PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol 7:496. https:\/\/doi.org\/10.1038\/msb.2011.26","journal-title":"Mol Syst Biol"},{"key":"1085_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.106127","volume":"150","author":"Y Gu","year":"2022","unstructured":"Gu Y, Zheng S, Yin Q, Jiang R, Li J (2022) Redda: integrating multiple biological relations to heterogeneous graph neural network for drug-disease association prediction. Comput Biol Med 150:106127. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106127","journal-title":"Comput Biol Med"},{"key":"1085_CR14","doi-asserted-by":"crossref","unstructured":"He C, Zhao Z, Wang X, Zheng H, Duan L, Zuo J  (2024) Exploring drug-target interaction prediction on cold-start scenarios via meta-learning-based graph transformer. Methods","DOI":"10.1016\/j.ymeth.2024.11.010"},{"key":"1085_CR15","unstructured":"Hu W, Liu B, Gomes J, Zitnik M, Liang P, Pande V, Leskovec J  (2020) Strategies For Pre-training Graph Neural Networks. In: International Conference on Learning Representations (ICLR)."},{"issue":"4","key":"1085_CR16","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1109\/JBHI.2024.3363080","volume":"28","author":"S Huang","year":"2024","unstructured":"Huang S, Wang M, Zheng X, Chen J, Tang C (2024) Hierarchical and dynamic graph attention network for drug-disease association prediction. IEEE J Biomed Health Inform 28(4):2416\u20132427","journal-title":"IEEE J Biomed Health Inform"},{"issue":"2","key":"1085_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000197864","volume":"17","author":"Y Inaba","year":"2009","unstructured":"Inaba Y, D\u2019Antuono M, Bertazzoni G, Biagini G, Avoli M (2009) Diminished presynaptic GABA(B) receptor function in the neocortex of a genetic model of absence epilepsy. Neurosignals 17(2):121\u2013131. https:\/\/doi.org\/10.1159\/000197864","journal-title":"Neurosignals"},{"issue":"1","key":"1085_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1021\/acs.jcim.7b00616","volume":"58","author":"S Jaeger","year":"2018","unstructured":"Jaeger S, Fulle S, Turk S (2018) Mol2vec: unsupervised machine learning approach with chemical intuition. J Chem Inf Model 58(1):27\u201335. https:\/\/doi.org\/10.1021\/acs.jcim.7b00616","journal-title":"J Chem Inf Model"},{"issue":"1","key":"1085_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13321-020-00450-7","volume":"12","author":"TN Jarada","year":"2020","unstructured":"Jarada TN, Rokne JG, Alhajj R (2020) A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions. J Cheminform 12(1):46. https:\/\/doi.org\/10.1186\/s13321-020-00450-7","journal-title":"J Cheminform"},{"key":"1085_CR20","doi-asserted-by":"crossref","unstructured":"Jia X, Sun X, Wang K, Li M (2024) DRGCL: drug repositioning via semantic-enriched graph contrastive learning. IEEE J Biomed Health Inform.","DOI":"10.1109\/JBHI.2024.3372527"},{"issue":"9","key":"1085_CR21","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/jphp.13273","volume":"72","author":"JP Jourdan","year":"2020","unstructured":"Jourdan JP, Bureau R, Rochais C, Dallemagne P (2020) Drug repositioning: a brief overview. J Pharm Pharmacol 72(9):1145\u20131151. https:\/\/doi.org\/10.1111\/jphp.13273","journal-title":"J Pharm Pharmacol"},{"key":"1085_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae909","author":"M Kanehisa","year":"2024","unstructured":"Kanehisa M, Furumichi M, Sato Y, Matsuura Y, Ishiguro-Watanabe M (2024) KEGG: biological systems database as a model of the real world. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkae909","journal-title":"Nucleic Acids Res"},{"key":"1085_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101497","author":"Y Kim","year":"2022","unstructured":"Kim Y, Jung YS, Park JH, Kim SJ, Cho YR (2022) Drug-disease association prediction using heterogeneous networks for computational drug repositioning. Biomolecules. https:\/\/doi.org\/10.3390\/biom12101497","journal-title":"Biomolecules"},{"issue":"D1","key":"1085_CR24","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, Pon A, Cox J, Chin NEL, Strawbridge SA, Garcia-Patino M, Kruger R, Sivakumaran A, Sanford S, Doshi R, Khetarpal N, Fatokun O, Doucet D, Zubkowski A, Rayat DY, Jackson H, Harford K, Anjum A, Zakir M, Wang F, Tian S, Lee B, Liigand J, Peters H, Wang RQR, Nguyen T, So D, Sharp M, da Silva R, Gabriel C, Scantlebury J, Jasinski M, Ackerman D, Jewison T, Sajed T, Gautam V, Wishart DS (2024) DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res 52(D1):D1265\u2013D1275. https:\/\/doi.org\/10.1093\/nar\/gkad976","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1085_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1109\/3477.764879","volume":"29","author":"K Krishna","year":"1999","unstructured":"Krishna K, Murty MN (1999) Genetic K-means algorithm. IEEE Trans Syst Man Cybern Part B (Cybernetics) 29(3):433\u2013439","journal-title":"IEEE Trans Syst Man Cybern Part B (Cybernetics)"},{"issue":"5","key":"1085_CR26","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1177\/1078155219890653","volume":"26","author":"A Kunthur","year":"2020","unstructured":"Kunthur A (2020) A castrate-resistant metastatic prostate cancer patient with severe pancytopenia, successfully treated with docetaxel chemotherapy. J Oncol Pharm Pract 26(5):1254\u20131258","journal-title":"J Oncol Pharm Pract"},{"issue":"3","key":"1085_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1191\/0269215506cr940oa","volume":"20","author":"SM Leary","year":"2006","unstructured":"Leary SM, Gilpin P, Lockley L, Rodriguez L, Jarrett L, Stevenson VL (2006) Intrathecal baclofen therapy improves functional intelligibility of speech in cerebral palsy. Clin Rehabil 20(3):228\u2013231. https:\/\/doi.org\/10.1191\/0269215506cr940oa","journal-title":"Clin Rehabil"},{"issue":"1","key":"1085_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12539-023-00593-9","volume":"16","author":"S Lei","year":"2024","unstructured":"Lei S, Lei X, Chen M, Pan Y (2024) Drug repositioning based on deep sparse autoencoder and drug-disease similarity. Interdiscip Sci Comput Life Sci 16(1):160\u2013175","journal-title":"Interdiscip Sci Comput Life Sci"},{"key":"1085_CR29","doi-asserted-by":"crossref","unstructured":"Li M, Xu S, Cai X, Zhang Z, Ji H (2022)  Contrastive meta-learning for drug-target binding affinity prediction. In: 2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM),  IEEE, pp 464\u2013470.","DOI":"10.1109\/BIBM55620.2022.9995372"},{"issue":"41","key":"1085_CR30","doi-asserted-by":"publisher","first-page":"27233","DOI":"10.1021\/acsomega.1c04017","volume":"6","author":"M Li","year":"2021","unstructured":"Li M, Zhou J, Hu J, Fan W, Zhang Y, Gu Y, Karypis G (2021) Dgl-lifesci: an open-source toolkit for deep learning on graphs in life science. ACS Omega 6(41):27233\u201327238","journal-title":"ACS Omega"},{"issue":"9","key":"1085_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002139","volume":"7","author":"YY Li","year":"2011","unstructured":"Li YY, An J, Jones SJ (2011) A computational approach to finding novel targets for existing drugs. PLoS Comput Biol 7(9):e1002139. https:\/\/doi.org\/10.1371\/journal.pcbi.1002139","journal-title":"PLoS Comput Biol"},{"issue":"17","key":"1085_CR32","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1093\/bioinformatics\/btw228","volume":"32","author":"H Luo","year":"2016","unstructured":"Luo H, Wang J, Li M, Luo J, Peng X, Wu FX, Pan Y (2016) Drug repositioning based on comprehensive similarity measures and bi-random walk algorithm. Bioinformatics 32(17):2664\u20132671. https:\/\/doi.org\/10.1093\/bioinformatics\/btw228","journal-title":"Bioinformatics"},{"key":"1085_CR33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.clineuro.2014.05.024","volume":"123","author":"K Margetis","year":"2014","unstructured":"Margetis K, Korfias S, Boutos N, Gatzonis S, Themistocleous M, Siatouni A, Dalivigka Z, Flaskas T, Stranjalis G, Boviatsis E, Sakas D (2014) Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia. Clin Neurol Neurosurg 123:142\u2013145. https:\/\/doi.org\/10.1016\/j.clineuro.2014.05.024","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"1085_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/jnnp.72.2.275","volume":"72","author":"G Marquardt","year":"2002","unstructured":"Marquardt G, Seifert V (2002) Use of intrathecal baclofen for treatment of spasticity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 72(2):275\u2013276. https:\/\/doi.org\/10.1136\/jnnp.72.2.275","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1085_CR35","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.urology.2008.05.032","volume":"72","author":"S Marur","year":"2008","unstructured":"Marur S, Eliason J, Heilbrun LK, Dickow B, Smith DW, Baranowski K, Alhasan S, Vaishampayan U (2008) Phase II trial of capecitabine and weekly docetaxel in metastatic renal cell carcinoma. Urology 72(4):898\u2013902. https:\/\/doi.org\/10.1016\/j.urology.2008.05.032","journal-title":"Urology"},{"issue":"19","key":"1085_CR36","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1200\/JCO.2005.03.1161","volume":"24","author":"JM McKiernan","year":"2006","unstructured":"McKiernan JM, Masson P, Murphy AM, Goetzl M, Olsson CA, Petrylak DP, Desai M, Benson MC (2006) Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy. J Clin Oncol 24(19):3075\u20133080. https:\/\/doi.org\/10.1200\/JCO.2005.03.1161","journal-title":"J Clin Oncol"},{"issue":"2","key":"1085_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab581","volume":"23","author":"Y Meng","year":"2022","unstructured":"Meng Y, Lu C, Jin M, Xu J, Zeng X, Yang J (2022) A weighted bilinear neural collaborative filtering approach for drug repositioning. Brief Bioinform 23(2):bbab581","journal-title":"Brief Bioinform"},{"issue":"1","key":"1085_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad431","volume":"25","author":"Y Meng","year":"2024","unstructured":"Meng Y, Wang Y, Xu J, Lu C, Tang X, Peng T, Zhang B, Tian G, Yang J (2024) Drug repositioning based on weighted local information augmented graph neural network. Brief Bioinform 25(1):bbad431","journal-title":"Brief Bioinform"},{"issue":"7","key":"1085_CR39","first-page":"3725","volume":"36","author":"D Miyahara","year":"2016","unstructured":"Miyahara D, Katsuta T, Maehara M, Takahashi Y, Fukagawa S, Miyata K, Kiyoshima C, Yotsumoto F, Anan H, Miyamoto S (2016) Safety and anti-tumor effects of docetaxel plus cisplatin in intermediate- and high-risk endometrial cancer. Anticancer Res 36(7):3725\u20133729","journal-title":"Anticancer Res"},{"key":"1085_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104490","volume":"106","author":"K Mohamed","year":"2021","unstructured":"Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N (2021) Computational drug discovery and repurposing for the treatment of COVID-19: a systematic review. Bioorg Chem 106:104490. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104490","journal-title":"Bioorg Chem"},{"issue":"2","key":"1085_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10844-022-00698-5","volume":"59","author":"DK Panda","year":"2022","unstructured":"Panda DK, Ray S (2022) Approaches and algorithms to mitigate cold start problems in recommender systems: a systematic literature review. J Intell Inf Syst 59(2):341\u2013366","journal-title":"J Intell Inf Syst"},{"key":"1085_CR42","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.csbj.2020.04.004","volume":"18","author":"D Parisi","year":"2020","unstructured":"Parisi D, Adasme MF, Sveshnikova A, Bolz SN, Moreau Y, Schroeder M (2020) Drug repositioning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs. Comput Struct Biotechnol J 18:1043\u20131055. https:\/\/doi.org\/10.1016\/j.csbj.2020.04.004","journal-title":"Comput Struct Biotechnol J"},{"key":"1085_CR43","doi-asserted-by":"crossref","unstructured":"Peng L, Yang C, Yang J, Tu Y, Yu Q, Li Z, Chen M, Liang W (2024)  Drug repositioning via multi-view representation learning with heterogeneous graph neural network. IEEE J Biomed Health Inform.","DOI":"10.1109\/JBHI.2024.3434439"},{"issue":"6","key":"1085_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/WNF.0000000000000179","volume":"39","author":"A Perez-Arredondo","year":"2016","unstructured":"Perez-Arredondo A, Cazares-Ramirez E, Carrillo-Mora P, Martinez-Vargas M, Cardenas-Rodriguez N, Coballase-Urrutia E, Alemon-Medina R, Sampieri A 3rd, Navarro L, Carmona-Aparicio L (2016) Baclofen in the therapeutic of sequele of traumatic brain injury: spasticity. Clin Neuropharmacol 39(6):311\u2013319. https:\/\/doi.org\/10.1097\/WNF.0000000000000179","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"1085_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18(1):41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"1085_CR46","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/ci100050t","volume":"50","author":"D Rogers","year":"2010","unstructured":"Rogers D, Hahn M (2010) Extended-connectivity fingerprints. J Chem Inf Model 50(5):742\u2013754. https:\/\/doi.org\/10.1021\/ci100050t","journal-title":"J Chem Inf Model"},{"issue":"1","key":"1085_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/cncr.10202","volume":"94","author":"DP Ryan","year":"2002","unstructured":"Ryan DP, Kulke MH, Fuchs CS, Grossbard ML, Grossman SR, Morgan JA, Earle CC, Shivdasani R, Kim H, Mayer RJ, Clark JW (2002) A phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma. Cancer 94(1):97\u2013103. https:\/\/doi.org\/10.1002\/cncr.10202","journal-title":"Cancer"},{"issue":"1","key":"1085_CR48","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/10717544.2016.1253798","volume":"24","author":"TK Shaw","year":"2017","unstructured":"Shaw TK, Mandal D, Dey G, Pal MM, Paul P, Chakraborty S, Ali KA, Mukherjee B, Bandyopadhyay AK, Mandal M (2017) Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor. Drug Deliv 24(1):346\u2013357. https:\/\/doi.org\/10.1080\/10717544.2016.1253798","journal-title":"Drug Deliv"},{"issue":"3","key":"1085_CR49","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/ana.410250308","volume":"25","author":"I Shoulson","year":"1989","unstructured":"Shoulson I, Odoroff C, Oakes D, Behr J, Goldblatt D, Caine E, Kennedy J, Miller C, Bamford K, Rubin A (1989) A controlled clinical trial of baclofen as protective therapy in early Huntington\u2019s disease. Ann Neurol 25(3):252\u2013259","journal-title":"Ann Neurol"},{"issue":"3","key":"1085_CR50","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0014-2999(92)90623-C","volume":"213","author":"OC Snead III","year":"1992","unstructured":"Snead OC III (1992) Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures. Eur J Pharmacol 213(3):343\u2013349","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"1085_CR51","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1109\/JBHI.2022.3194891","volume":"26","author":"X Sun","year":"2022","unstructured":"Sun X, Wang B, Zhang J, Li M (2022) Partner-specific drug repositioning approach based on graph convolutional network. IEEE J Biomed Health Inform 26(11):5757\u20135765. https:\/\/doi.org\/10.1109\/JBHI.2022.3194891","journal-title":"IEEE J Biomed Health Inform"},{"issue":"D1","key":"1085_CR52","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S (2023) The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51(D1):D638\u2013D646","journal-title":"Nucleic Acids Res"},{"key":"1085_CR53","unstructured":"UniProt: the Universal protein knowledgebase in 2025 (2025). Nucleic acids research \n 53(D1):D609-D617"},{"key":"1085_CR54","unstructured":"Van der Maaten L, Hinton G (2008) Visualizing data using t-SNE. J Machine Learning Res 9 (11)"},{"issue":"26","key":"1085_CR55","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.3748\/wjg.v11.i26.4003","volume":"11","author":"Q-W Wang","year":"2005","unstructured":"Wang Q-W, L\u00fc H-L, Song C-C, Liu H, Xu C-G (2005) Radiosensitivity of human colon cancer cell enhanced by immunoliposomal docetaxel. World J Gastroenterol: WJG 11(26):4003","journal-title":"World J Gastroenterol: WJG"},{"key":"1085_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-7-S5-S6","volume":"7","author":"C Wu","year":"2013","unstructured":"Wu C, Gudivada RC, Aronow BJ, Jegga AG (2013) Computational drug repositioning through heterogeneous network clustering. BMC Syst Biol 7:1\u20139","journal-title":"BMC Syst Biol"},{"issue":"11 Pt 1","key":"1085_CR57","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1158\/1078-0432.CCR-05-2425","volume":"12","author":"K Yoshida","year":"2006","unstructured":"Yoshida K, Ninomiya M, Takakura N, Hirabayashi N, Takiyama W, Sato Y, Todo S, Terashima M, Gotoh M, Sakamoto J, Nishiyama M (2006) Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. Clin Cancer Res 12(11 Pt 1):3402\u20133407. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-2425","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1085_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa243","volume":"22","author":"Z Yu","year":"2021","unstructured":"Yu Z, Huang F, Zhao X, Xiao W, Zhang W (2021) Predicting drug\u2013disease associations through layer attention graph convolutional network. Brief Bioinform 22(4):bbaa243","journal-title":"Brief Bioinform"},{"issue":"24","key":"1085_CR59","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1093\/bioinformatics\/btz418","volume":"35","author":"X Zeng","year":"2019","unstructured":"Zeng X, Zhu S, Liu X, Zhou Y, Nussinov R, Cheng F (2019) Deepdr: a network-based deep learning approach to in silico drug repositioning. Bioinformatics 35(24):5191\u20135198. https:\/\/doi.org\/10.1093\/bioinformatics\/btz418","journal-title":"Bioinformatics"},{"key":"1085_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2023.121855","volume":"238","author":"P Zhang","year":"2024","unstructured":"Zhang P, Che C, Jin B, Yuan J, Li R, Zhu Y (2024) NCH-DDA: Neighborhood contrastive learning heterogeneous network for drug\u2013disease association prediction. Expert Syst Appl 238:121855","journal-title":"Expert Syst Appl"},{"issue":"1","key":"1085_CR61","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab515","volume":"23","author":"B-W Zhao","year":"2022","unstructured":"Zhao B-W, Hu L, You Z-H, Wang L, Su X-R (2022) HINGRL: predicting drug\u2013disease associations with graph representation learning on heterogeneous information networks. Brief Bioinform 23(1):bbab515","journal-title":"Brief Bioinform"},{"issue":"1","key":"1085_CR62","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13321-024-00848-7","volume":"16","author":"X Zheng","year":"2024","unstructured":"Zheng X, Tomiura Y (2024) A BERT-based pretraining model for extracting molecular structural information from a SMILES sequence. J Cheminform 16(1):71","journal-title":"J Cheminform"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-025-01085-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13321-025-01085-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-025-01085-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T09:44:27Z","timestamp":1760435067000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-025-01085-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1085"],"URL":"https:\/\/doi.org\/10.1186\/s13321-025-01085-2","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}